A Phase 3 trial of etripamil in the at-home setting enrolling patients with confirmed diagnosis of atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular re-entry tachycardia (AVRT).
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Etripamil (Primary)
- Indications Paroxysmal supraventricular tachycardia
- Focus Adverse reactions
- 10 Mar 2017 New trial record